17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters
about
Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancerBinary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapyHydroxybenzothiazoles as new nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1)Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.The Role of Androgens in Normal and Malignant Breast Tissue.Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosis.Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma.The stimulation of HSD17B7 expression by estradiol provides a powerful feed-forward mechanism for estradiol biosynthesis in breast cancer cells.Expression of Estrogen Sulfotransferase 1E1 and Steroid Sulfatase in Breast Cancer: A Immunohistochemical Study17beta-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer.Human 3β-hydroxysteroid dehydrogenase type 1 in human breast cancer: clinical significance and prognostic associations.Promoter Methylation Status of Breast Cancer Susceptibility Gene 1 and 17 Beta Hydroxysteroid Dehydrogenase Type 1 Gene in Sporadic Breast Cancer Patients.Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years.Regulation of 17β-hydroxysteroid dehydrogenases in cancer: regulating steroid receptor at pre-receptor stage.IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer.Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma.The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer.Immunohistochemical expression of gonadotropin releasing hormone receptor in human breast carcinoma.Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers.Increased 5α-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation.Endogenous secretory receptor for advanced glycation end products in non-small cell lung carcinoma.
P2860
Q24794121-880EFC27-421D-4D19-A16F-5BB2C1EDD98CQ27658290-8479FF06-3BC1-41A3-91D1-EC6504B5F3ADQ28478724-2830FBA0-731C-460E-8A67-357B22D3F736Q33728381-065CB9EF-B14F-42A3-9DE9-DE9D897397C9Q34096288-EFC26EFB-4387-4B03-B8C8-FBCD0F0BA4B3Q34487793-7C9D9A06-BFFA-4DBC-B87E-D70A4D936F92Q34672910-59707294-D11B-4B5E-A317-8B88F73DEFA6Q34856382-46EFB4C6-C88B-48B5-BA11-6525BCC31146Q34908906-82628935-9C1A-4BD4-96BB-A73C0336EF26Q36617036-B1655D01-5588-4E04-9896-968EA0436E3BQ36892987-9D1B7134-808B-4D10-9DBF-7FCDC95E8A36Q37060670-F80E54DB-264E-458A-A1D9-C397330034E6Q37360182-DEEE7EE3-6937-4C4D-81D6-2BA9551B1209Q37989094-FBF0588B-31F6-4705-A9DE-C7099D9C39C0Q38631164-5FB52C8F-A22B-4281-98E0-C305A8927B6AQ39253863-1A8C8042-E1BD-450D-9855-24D68277A95FQ41867466-2EBF240D-3475-4E95-94B5-F4E8CD05BCB0Q43651286-B9926687-1B11-4D82-81B3-2CD429FB1469Q43824457-55C2D8B9-3D37-49C6-B8AF-979F0BA2BFC2Q51437937-91A5C2F4-F029-4CA3-A3D7-F74684D57D94Q54577822-3F35AFA4-54BB-4BFD-926B-D9B9678DBDC1
P2860
17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters
description
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im Februar 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/02/01)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/02/01)
@nl
наукова стаття, опублікована в лютому 2000
@uk
مقالة علمية (نشرت في فبراير 2000)
@ar
name
17Beta-hydroxysteroid dehydrog ...... clinicopathological parameters
@ast
17Beta-hydroxysteroid dehydrog ...... clinicopathological parameters
@en
17Beta-hydroxysteroid dehydrog ...... clinicopathological parameters
@nl
type
label
17Beta-hydroxysteroid dehydrog ...... clinicopathological parameters
@ast
17Beta-hydroxysteroid dehydrog ...... clinicopathological parameters
@en
17Beta-hydroxysteroid dehydrog ...... clinicopathological parameters
@nl
prefLabel
17Beta-hydroxysteroid dehydrog ...... clinicopathological parameters
@ast
17Beta-hydroxysteroid dehydrog ...... clinicopathological parameters
@en
17Beta-hydroxysteroid dehydrog ...... clinicopathological parameters
@nl
P2093
P2860
P3181
P356
P1476
17Beta-hydroxysteroid dehydrog ...... clinicopathological parameters
@en
P2093
P2860
P2888
P304
P3181
P356
10.1054/BJOC.1999.0956
P407
P577
2000-02-01T00:00:00Z
P5875
P6179
1048424107